ArticleThe Journal of biological chemistry2025

Patient-derived organotypic tissue cultures as a platform to evaluate metabolic reprogramming in breast cancer patients.

Teresa W-M Fan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.